Lindholm, C., Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Ejerblad, E., Olesen, G., Björklund, A., Kittang, A. O., Werlenius, O., Wiggh, J., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Moen, A., Lundström, L., Bahr, L. V., Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbaek, K., Mielke, S., Jacobsen, S., Ebeling, F., Cavelier, L., Friis, L. S., Dybedal, I., & Hellstrom-Lindberg, E. (n.d.). topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS. Leukemia research, 128, . http://access.bl.uk/ark:/81055/vdc_100184748555.0x00004a